Literature DB >> 17179863

Alpha-synuclein potentiates Ca2+ influx through voltage-dependent Ca2+ channels.

Agata Adamczyk1, Joanna B Strosznajder.   

Abstract

Alpha-synuclein localized in synaptic terminals plays an important role in the pathogenesis of neurodegenerative diseases. The central domain of the protein, the nonamyloid component, is probably responsible for alpha-synuclein toxicity. Here, we report that alpha-synuclein and its nonamyloid component induced Ca2+ influx in rat synaptoneurosomes. The effect of alpha-synuclein was eliminated by the N-type specific Ca2+ channel blocker, omega-conotoxin GVIA. The antioxidant, resveratrol, and the nitric oxide synthase inhibitor, Nomega-nitro-L-arginine, did not prevent alpha-synuclein-induced Ca2+ influx. Our findings indicate that alpha-synuclein stimulated Ca2+ influx through N-type voltage-dependent Ca2+ channels by a mechanism other than free radicals. A direct interaction between alpha-synuclein and N-type Ca2+ channels could be responsible for their effects on Ca2+ influx through voltage-dependent Ca2+ channels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17179863     DOI: 10.1097/WNR.0b013e3280115185

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  24 in total

1.  Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy.

Authors:  Christina R Bodner; Christopher M Dobson; Ad Bax
Journal:  J Mol Biol       Date:  2009-05-27       Impact factor: 5.469

2.  Calcineurin determines toxic versus beneficial responses to α-synuclein.

Authors:  Gabriela Caraveo; Pavan K Auluck; Luke Whitesell; Chee Yeun Chung; Valeriya Baru; Eugene V Mosharov; Xiaohui Yan; Manu Ben-Johny; Martin Soste; Paola Picotti; Hanna Kim; Kim A Caldwell; Guy A Caldwell; David Sulzer; David T Yue; Susan Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-13       Impact factor: 11.205

3.  The association between glaucoma prevalence and supplementation with the oxidants calcium and iron.

Authors:  Sophia Y Wang; Kuldev Singh; Shan C Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-13       Impact factor: 4.799

4.  α-Synuclein increases U251 cells vulnerability to hydrogen peroxide by disrupting calcium homeostasis.

Authors:  Zhengxin Ying; Fankai Lin; Weihong Gu; Yang Su; Abida Arshad; Hong Qing; Yulin Deng
Journal:  J Neural Transm (Vienna)       Date:  2011-02-20       Impact factor: 3.575

5.  Localization of synucleins in the mammalian cochlea.

Authors:  O Akil; C M Weber; S N Park; N Ninkina; V Buchman; L R Lustig
Journal:  J Assoc Res Otolaryngol       Date:  2008-07-30

Review 6.  Alpha-synuclein modulates dopamine neurotransmission.

Authors:  Brittany Butler; Danielle Sambo; Habibeh Khoshbouei
Journal:  J Chem Neuroanat       Date:  2016-06-19       Impact factor: 3.052

7.  Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux.

Authors:  Roberta Marongiu; Brian Spencer; Leslie Crews; Anthony Adame; Christina Patrick; Margarita Trejo; Bruno Dallapiccola; Enza Maria Valente; Eliezer Masliah
Journal:  J Neurochem       Date:  2009-01-24       Impact factor: 5.372

8.  An extracellular mechanism that can explain the neurotoxic effects of α-synuclein aggregates in the brain.

Authors:  C Pacheco; L G Aguayo; C Opazo
Journal:  Front Physiol       Date:  2012-07-26       Impact factor: 4.566

9.  Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy.

Authors:  Christina R Bodner; Alexander S Maltsev; Christopher M Dobson; Ad Bax
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

10.  Exogenous α-synuclein decreases raft partitioning of Cav2.2 channels inducing dopamine release.

Authors:  Giuseppe Ronzitti; Giovanna Bucci; Marco Emanuele; Damiana Leo; Tatyana D Sotnikova; Liudmila V Mus; Camille H Soubrane; Mark L Dallas; Agnes Thalhammer; Lorenzo A Cingolani; Sumiko Mochida; Raul R Gainetdinov; Gary J Stephens; Evelina Chieregatti
Journal:  J Neurosci       Date:  2014-08-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.